On 26 September 2025 the Medicines and Healthcare products Regulatory Agency established the National Commission into the Regulation of AI in Healthcare. The Commission is an expert, non-statutory advisory body. Its remit covers software and AI-enabled medical devices, and wider questions of accountability, transparency, clinical practice, organisational governance and system-wide assurance.

Neil Lawrence is a commissioner and chairs the Technology Working Group, which identifies and evaluates frontier AI technologies and how they interact with regulation. The group’s project page records the Cambridge role.